Literature DB >> 8676677

Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin?

P Brennan1, B Ollier, J Worthington, A Hajeer, A Silman.   

Abstract

The risk of rheumatoid arthritis (RA) seems to be associated with reduced fecundity and with breastfeeding; these apparently contradictory risk factors can be explained by their association with high prolactin concentrations. The only consistent genetic association with RA is for genes encoded in the HLA complex, particularly HLA DR4. We have identified some data indicating that the effects of breastfeeding and nulliparity are modified by HLA DR4 status, suggesting an interaction between genetic and reproductive risk factors in the aetiology of RA. The prolactin gene is in close proximity to the HLA region on the short arm of chromosome six. We therefore propose the hypothesis that the associations between DR4 and reproductive risk factors in RA are due to linkage disequilibrium between DR4 and an abnormally regulated prolactin gene polymorphism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676677     DOI: 10.1016/s0140-6736(96)02037-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

1.  Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients.

Authors:  Hedi Orbach; Gisele Zandman-Goddard; Mona Boaz; Nancy Agmon-Levin; Howard Amital; Zoltan Szekanecz; Gabriella Szucs; Josef Rovensky; Emese Kiss; Andrea Doria; Anna Ghirardello; Jesus Gomez-Arbesu; Ljudmila Stojanovich; Francesca Ingegnoli; Pier Luigi Meroni; Blaz' Rozman; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 2.  Hypophyseal-pituitary-adrenal axis in autoimmune and rheumatic diseases.

Authors:  B H Athreya; P Rettig; W V Williams
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

3.  Comorbidity and lifestyle, reproductive factors, and environmental exposures associated with rheumatoid arthritis.

Authors:  A Reckner Olsson; T Skogh; G Wingren
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

4.  Increased risk for clinical onset of myasthenia gravis during the postpartum period.

Authors:  Marion I Boldingh; Angelina H Maniaol; Cathrine Brunborg; Harald Weedon-Fekjær; Jan J G M Verschuuren; Chantal M E Tallaksen
Journal:  Neurology       Date:  2016-10-21       Impact factor: 9.910

5.  Pregnancy and early onset pauciarticular juvenile chronic arthritis.

Authors:  E Musiej-Nowakowska; R Ploski
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

Review 6.  Dual Roles of Prolactin and Vasoinhibin in Inflammatory Arthritis.

Authors:  Carmen Clapp; Georgina Ortiz; Jose F García-Rodrigo; María G Ledesma-Colunga; Oscar F Martínez-Díaz; Norma Adán; Gonzalo Martínez de la Escalera
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-02       Impact factor: 6.055

Review 7.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

8.  Replication of Associations of Genetic Loci Outside the HLA Region With Susceptibility to Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.

Authors:  Sebastien Viatte; Jonathan Massey; John Bowes; Kate Duffus; Stephen Eyre; Anne Barton; Jane Worthington
Journal:  Arthritis Rheumatol       Date:  2016-07       Impact factor: 10.995

Review 9.  Why are women predisposed to autoimmune rheumatic diseases?

Authors:  Jacqueline E Oliver; Alan J Silman
Journal:  Arthritis Res Ther       Date:  2009-10-26       Impact factor: 5.156

10.  Early menopause and severity of rheumatoid arthritis in women older than 45 years.

Authors:  Mitra Pikwer; Jan-Åke Nilsson; Ulf Bergström; Lennart T H Jacobsson; Carl Turesson
Journal:  Arthritis Res Ther       Date:  2012-08-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.